1. Beta Bionics Projects $131M-$136M 2026 Revenue, Lifts Gross Margin Outlook to 57.5%-59.5%
Beta Bionics has issued a significant financial projection, forecasting 2026 revenue in the range of $131 million to $136 million. In a parallel move signaling confidence in its operational efficiency, the company has also raised its long-term gross margin outlook to a robust 57.5% to 59.5%. This dual announcement mark...